Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Soft tissue neoplasms malignant and unspecified
ADR ID BADD_A06704
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.33      Soft tissue neoplasms malignant and unspecified
Description Not Available
MedDRA Code 10072990
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Not Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01252Leflunomide0.000643%
BADD_D01253Lenalidomide0.001567%
BADD_D01281Levonorgestrel0.001655%
BADD_D01372Megestrol acetate--
BADD_D01376Melphalan0.000224%
BADD_D01401Metformin0.000011%
BADD_D01418Methotrexate0.000114%
BADD_D01496Montelukast0.000015%
BADD_D01508Mycophenolic acid--
BADD_D01633Oxaliplatin0.000168%
BADD_D01654Palbociclib0.000246%
BADD_D01687Pazopanib0.004589%
BADD_D01798Pomalidomide0.000651%
BADD_D01804Posaconazole--
BADD_D01831Prednisolone0.000262%
BADD_D01834Prednisone0.000188%
BADD_D01835Pregabalin0.000104%
BADD_D01881Pyridostigmine0.002125%
BADD_D01892Quinaprilat0.005438%
BADD_D01905Raltegravir0.001648%
BADD_D01906Raltegravir potassium--
BADD_D01913Ranitidine0.000088%
BADD_D01953Rituximab--
BADD_D01954Rivaroxaban0.000063%
BADD_D01978Ruxolitinib0.000137%
BADD_D01989Saquinavir mesylate--
BADD_D02028Sirolimus0.000335%
BADD_D02058Sorafenib0.000280%
BADD_D02100Sunitinib0.002697%
BADD_D02105Tacrolimus0.003267%
The 2th Page    First    Pre   2 3    Next   Last    Total 3 Pages
ADReCS-Target
ADR Term Drug Name Target